Wuxi AppTec Co (SHSE:603259) Retained Earnings : ¥35,680 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Wuxi AppTec Co's retained earnings for the quarter that ended in Mar. 2025 was ¥35,680 Mil.

Wuxi AppTec Co's quarterly retained earnings increased from Sep. 2024 (¥29,424 Mil) to Dec. 2024 (¥32,008 Mil) and increased from Dec. 2024 (¥32,008 Mil) to Mar. 2025 (¥35,680 Mil).

Wuxi AppTec Co's annual retained earnings increased from Dec. 2022 (¥19,136 Mil) to Dec. 2023 (¥25,773 Mil) and increased from Dec. 2023 (¥25,773 Mil) to Dec. 2024 (¥32,008 Mil).

Wuxi AppTec Co Retained Earnings Historical Data

The historical data trend for Wuxi AppTec Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuxi AppTec Co Retained Earnings Chart

Wuxi AppTec Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Retained Earnings

Get a 7-Day Free Trial

8,087.97

12,126.08

19,136.48

25,773.48

32,007.64

Wuxi AppTec Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Retained Earnings	Get a 7-Day Free Trial															27,715.69	27,131.25	29,424.36	32,007.64	35,679.60

Wuxi AppTec Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Wuxi AppTec Co (SHSE:603259) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Wuxi AppTec Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (SHSE:603259) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

WUXIF:USA WUXAY:USA 02359:Hong Kong WX8:Germany

Address

288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131

Website

https://www.wuxiapptec.com

Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by China, Europe, and other regions.

Executives

Chen Shu Hui	senior management
Yang	Director
Hu Zheng Guo	Director
	senior management
Yao Chi	Director
Chen Min	Director
Zhu Bi Xin	senior management
Yang	senior management
Chen Shu Hui	senior management
Hu Zheng Guo	Director

Wuxi AppTec Co Headlines

No Headlines